Bicycle Therapeutics plc (ADR)

General ticker "BCYC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.3B (TTM average)

Bicycle Therapeutics plc (ADR) follows the US Stock Market performance with the rate: 3.3%.

Estimated limits based on current volatility of 5.8%: low 8.14$, high 9.14$

Factors to consider:

  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [8.03$, 19.21$]
  • 2025-12-31 to 2026-12-31 estimated range: [6.64$, 15.85$]

Financial Metrics affecting the BCYC estimates:

  • Negative: Non-GAAP EPS, $ of -2.93 <= 0.04
  • Negative: Operating cash flow per share per price, % of -1.56 <= 1.79
  • Negative: negative Operating income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income
  • Negative: negative Industry operating income (median)
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82

Similar symbols

Short-term BCYC quotes

2025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-0666.577.588.599.5
Price $

Long-term BCYC plot with estimates

51015202530Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
BCYCS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $14.46MM $26.98MM $35.27MM
Operating Expenses $131.12MM $216.92MM $245.15MM
Operating Income $-116.65MM $-189.95MM $-209.87MM
Non-Operating Income $2.41MM $10.74MM $36.08MM
Interest Expense $3.34MM $3.26MM $1.73MM
R&D Expense $81.61MM $156.50MM $172.97MM
Income(Loss) $-114.24MM $-179.21MM $-173.80MM
Taxes $-1.52MM $1.46MM $-4.76MM
Profit(Loss)* $-112.72MM $-180.66MM $-169.03MM
Stockholders Equity $270.78MM $370.93MM $793.06MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $410.61MM $595.34MM $956.87MM
Operating Cash Flow $-86.11MM $-60.63MM $-164.72MM
Capital expenditure $18.99MM $2.93MM $1.24MM
Investing Cash Flow $-18.99MM $-2.93MM $-1.24MM
Financing Cash Flow $6.69MM $250.03MM $519.75MM
Earnings Per Share** $-3.80 $-5.08 $-0.29
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.